Annie McGuire
Known title: EVP, General CounselCIK: 0001914620
Associated companies
Transaction History
| VCYT | ▼ Sell | Open Market | 2,154 | $92K | 9/4/2026 | View on chart |
| VCYT | ▼ Sell | Open Market | 1,100 | $48K | 9/4/2026 | View on chart |
| VCYT | ▼ Sell | Tax Withholding | 3,215 | $144K | 9/2/2026 | View on chart |
| VCYT | ▼ Sell | Open Market | 1,400 | $69K | 6/4/2026 | View on chart |
| VCYT | ▼ Sell | Open Market | 1,776 | $89K | 6/4/2026 | View on chart |
| VCYT | ▼ Sell | Tax Withholding | 3,292 | $157K | 6/2/2026 | View on chart |
| VCYT | ▼ Sell | Open Market | 5,102 | $194K | 5/6/2026 | View on chart |
| VCYT | ▼ Sell | Open Market | 5,102 | $204K | 5/6/2026 | View on chart |
| VCYT | ▲ Buy | Grant | 32,892 | $0 | 3/6/2026 | View on chart |
| VCYT | ▲ Buy | Grant | 26,314 | $0 | 3/6/2026 | View on chart |
| VCYT | ▼ Sell | Open Market | 4,994 | $176K | 3/4/2026 | View on chart |
| VCYT | ▼ Sell | Open Market | 1,664 | $60K | 3/4/2026 | View on chart |
| VCYT | ▼ Sell | Tax Withholding | 6,902 | $249K | 3/2/2026 | View on chart |
| VCYT | ▲ Buy | Grant | 50,999 | $0 | 2/26/2026 | View on chart |
| VCYT | ▼ Sell | Tax Withholding | 10,867 | $421K | 2/26/2026 | View on chart |
| VCYT | ▼ Sell | Open Market | 100 | $4K | 12/16/2025 | View on chart |
| VCYT | ▼ Sell | Open Market | 10,639 | $459K | 12/16/2025 | View on chart |
| VCYT | ▼ Sell | Open Market | 720 | $34K | 12/4/2025 | View on chart |
| VCYT | ▼ Sell | Open Market | 702 | $33K | 12/4/2025 | View on chart |
| VCYT | ▼ Sell | Tax Withholding | 3,052 | $141K | 12/2/2025 | View on chart |
| VCYT | ▼ Sell | Open Market | 6,466 | $259K | 11/5/2025 | View on chart |
| VCYT | ▼ Sell | Open Market | 2,160 | $76K | 10/1/2025 | View on chart |
| VCYT | ▼ Sell | Open Market | 2,283 | $77K | 9/19/2025 | View on chart |
| VCYT | ▼ Sell | Tax Withholding | 3,507 | $106K | 9/2/2025 | View on chart |
| VCYT | ▼ Sell | Tax Withholding | 3,505 | $94K | 6/2/2025 | View on chart |
| VCYT | ▲ Buy | Grant | 30,200 | $0 | 3/6/2025 | View on chart |
| VCYT | ▼ Sell | Open Market | 1,142 | $38K | 3/4/2025 | View on chart |
| VCYT | ▼ Sell | Tax Withholding | 8,255 | $287K | 3/2/2025 | View on chart |
| VCYT | ▲ Buy | Grant | 13,466 | $0 | 2/27/2025 | View on chart |
| VCYT | ▼ Sell | Tax Withholding | 7,000 | $237K | 2/27/2025 | View on chart |
| VCYT | ▼ Sell | Open Market | 18,699 | $823K | 12/4/2024 | View on chart |
| VCYT | ▼ Sell | Tax Withholding | 1,918 | $85K | 12/2/2024 | View on chart |
| VCYT | ▼ Sell | Tax Withholding | 1,920 | $61K | 9/2/2024 | View on chart |
| VCYT | ▼ Sell | Tax Withholding | 1,919 | $40K | 6/2/2024 | View on chart |
| VCYT | ▲ Buy | Grant | 49,880 | $0 | 3/6/2024 | View on chart |
| VCYT | ▼ Sell | Tax Withholding | 4,347 | $104K | 3/2/2024 | View on chart |
| VCYT | ▼ Sell | Tax Withholding | 803 | $21K | 12/2/2023 | View on chart |
| VCYT | ▼ Sell | Tax Withholding | 1,729 | $46K | 9/2/2023 | View on chart |
| VCYT | ▼ Sell | Tax Withholding | 494 | $13K | 6/2/2023 | View on chart |
| VCYT | ▲ Buy | Grant | 23,413 | $0 | 3/6/2023 | View on chart |
| VCYT | ▼ Sell | Tax Withholding | 2,152 | $52K | 3/2/2023 | View on chart |
| VCYT | ▲ Buy | Grant | 10,702 | $0 | 8/5/2022 | View on chart |
| VCYT | ▲ Buy | Grant | 22,855 | $0 | 2/28/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 11, 2026
Veracyte (VCYT) Stock Seen as Undervalued After 107% Rise
Recent coverage notes that Veracyte’s shares have risen more than 100% while still appearing inexpensive relative to its earnings multiple. The company’s trailing P/E of about 30.6 and an analyst consensus target near $58 suggest the market may be pricing in further upside. The stock is currently trading near the lower end of its 52‑week range, close to a support level that has been tested multiple times.
Veracyte (VCYT) Stock Seen as Undervalued After 107% Rise. Recent coverage notes that Veracyte’s shares have risen more than 100% while still appearing inexpensive relative to its earnings multiple. The company’s trailing P/E of about 30.6 and an analyst consensus target near $58 suggest the market may be pricing in further upside. The stock is currently trading near the lower end of its 52‑week range, close to a support level that has been tested multiple times.